Expression of an anti-botulinum toxin A neutralizing single-chain Fv recombinant antibody in transgenic tobacco (Q81594543)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16337316%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

title

Expression of an anti-botulinum toxin A neutralizing single-chain Fv recombinant antibody in transgenic tobacco (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16337316%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

Kurt C Almquist

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16337316%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Michael D McLean

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16337316%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Yongqing Niu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16337316%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Greg Byrne

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16337316%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Fernando C Olea-Popelka

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16337316%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Coral Murrant

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16337316%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Jack Barclay

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16337316%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

J Christopher Hall

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16337316%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

publication date

1 December 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16337316%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16337316%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16337316%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16337316%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

page(s)

2079-2086

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16337316%20AND%20SRC:MED&resulttype=core&format=json

Botulinum Toxin as a Biological Weapon: Medical and Public Health Management

10 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.014

Experimental botulism in monkeys--a clinical pathological study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.014

Systemic toxicity of botulinum toxin by intramuscular injection in the monkey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.014

Passive antibody administration (immediate immunity) as a specific defense against biological weapons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.014

Equine antitoxin use and other factors that predict outcome in type A foodborne botulism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.014

Experience with the use of an investigational F(ab')2 heptavalent botulism immune globulin of equine origin during an outbreak of type E botulism in Egypt

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.014

Protection against botulinum toxins provided by passive immunization with botulinum human immune globulin: evaluation using an inhalation model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.014

Passive antibody therapies: progress and continuing challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.014

Pathogen-specific recombinant human polyclonal antibodies: biodefence applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.014

Generation and production of engineered antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.014

Plant biopharming of monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.014

Production and glycosylation of plant-made pharmaceuticals: the antibodies as a challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.014

Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.014

Increasing expression of an anti-picloram single-chain variable fragment (ScFv) antibody and resistance to picloram in transgenic tobacco (Nicotiana tabacum).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.014

The C-terminal KDEL sequence increases the expression level of a single-chain antibody designed to be targeted to both the cytosol and the secretory pathway in transgenic tobacco

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.014

Isolation and Characterization of the Genes Encoding Basic and Acidic Chitinase in Arabidopsis thaliana

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.014

The pFF plasmids: cassettes utilising CaMV sequences for expression of foreign genes in plants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.014

BinaryAgrobacteriumvectors for plant transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.014

Immunomodulation confers herbicide resistance in plants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.014

Quantitative analysis of c-myc-tagged protein in crude cell extracts using fluorescence polarization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.014

Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: experience in 26 cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.014

Initial postmarketing experience with crotalidae polyvalent immune Fab for treatment of rattlesnake envenomation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.014

Development of neutralising human recombinant antibodies to pertussis toxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.014

Neutralizing human anti crotoxin scFv isolated from a nonimmunized phage library

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.014

A strategy for the generation of specific human antibodies by directed evolution and phage display. An example of a single-chain antibody fragment that neutralizes a major component of scorpion venom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.014

Construction and functional evaluation of a single-chain antibody fragment that neutralizes toxin AahI from the venom of the scorpion Androctonus australis hector.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.014

Opportunities for recombinant antigen and antibody expression in transgenic plants--technology assessment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.014

Prolonged circulating lives of single-chain Fv proteins conjugated with polyethylene glycol: a comparison of conjugation chemistries and compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.014

Albumin binding as a general strategy for improving the pharmacokinetics of proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.014

Retargeting serum immunoglobulin with bispecific diabodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.014

High avidity scFv multimers; diabodies and triabodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.014

Engineering high affinity superantigens by phage display

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.014

Deciphering antibody properties that lead to potent botulinum neurotoxin neutralization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.014

Functional analysis of Bacillus anthracis protective antigen by using neutralizing monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.014

Uncorking the biomanufacturing bottleneck

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.014

Bioprospecting in plants for engineered proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.014

Puzzling industry response to ProdiGene fiasco

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.014

Starlink corn: a risk analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.014

Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.014

Antibodies and genetically engineered related molecules: production and purification.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.014

Molecular characterization of murine humoral immune response to botulinum neurotoxin type A binding domain as assessed by using phage antibody libraries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.014

inferred from DOI database lookup

7 January 2021

based on heuristic

Redirecting circulating antibodies via ligand-hapten conjugates eliminates target cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.014

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2005.11.014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16337316%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference